American Immunization Registry Association, Washington, D.C., United States.
American Immunization Registry Association, Washington, D.C., United States.
Int J Med Inform. 2021 Apr;148:104412. doi: 10.1016/j.ijmedinf.2021.104412. Epub 2021 Feb 8.
IIS are important tools in the public health system and exist to improve and protect the nation's health from vaccine-preventable diseases. A network of 62 independent state, territorial, and jurisdictional immunization information systems (IIS) are operated within the United States. These systems are relied upon to implement an increasingly complex vaccination schedule, consolidate and create comprehensive immunization records, as well as monitor vaccine safety, efficacy, and support vaccine delivery. Despite their importance and necessity, the number of varying systems, coupled with jurisdictional policy and resource limitations, presents challenges with standardization, interoperability, data exchange, and the capture of complete immunization records. In partnership with the Centers for Disease Control (CDC) and IIS partners, the American Immunization Registry Association (AIRA) instituted its Measurement and Improvement (M&I) Initiative in 2015 as an innovative effort to evaluate and increase alignment of IIS with national functional standards. Lessons and strategies can be adapted for broader implementation as global systems develop methods to better achieve 2030 Sustainable Development Goal (SDG) targets, particularly related to global population health and infrastructure.
AIRA works closely with its partners to propose, vet, and refine processes and measures that can be compared across IIS, resulting in a uniform, standardized approach for measurement. The M&I Initiative is conducted as a third-party, independent evaluation through AIRA connecting with IIS pre-production systems to test the IIS response to test messages and measures across multiple content areas prioritized by the IIS community. The process includes three stages: 1) Testing and Discovery, 2) Assessment, and 3) Validation. Content areas currently evaluated include clinical decision support, interoperability transport, HL7 submission/acknowledgement, HL7 message query/response, and data quality. Testing is performed using the AIRA-developed Aggregate Analysis Reporting Tool (AART), an electronic testing tool and user interface specifically designed to compile and visualize results from the measures and tests.
The M&I Initiative is voluntary with 86 percent (50/58) of the IIS programs targeted for measurement participating as of Spring 2020. To date, AIRA has actively measured standards alignment and published data on Validation in the first three content areas of Transport, Submission/Acknowledgement, and Query/Response. Thirty-one individual IIS have been validated in at least two of these three content areas. The number of IIS meeting one primary Transport measure has increased from 19 to 39 in three years, an increase of 105 percent. The number of IIS who were able to process the submission of a correctly formatted full immunization record for a patient jumped from 17 to 34, a 200 percent increase from baseline. Similarly, the number of IIS sending standards-conformant HL7 Acknowledgment messages has increased fourteen-fold since measurement began in 2017. The number of IIS who were able to process and respond to a query requesting a patient's evaluated immunization record and forecast increased from nine to 42, a 367 percent increase from baseline. Within the first two quarters of assessment, the percentage of IIS meeting the CDS measures aimed at supporting IIS alignment with ACIP recommendations increased 15 percent from baseline.
The M&I initiative has helped to reduce variability across IIS and strengthen immunization data in IIS that is more complete, accurate, and can be utilized with confidence. The successes and experience offer an innovative model that could be adapted to standardize measures of success and data-sharing capabilities across global borders, particularly of value in achieving SDGs aimed at ensuring healthy lives and promoting well-being for all ages through strengthened immunization systems.
免疫信息系统 (IIS) 是公共卫生系统中的重要工具,旨在通过预防疫苗可预防的疾病来改善和保护国家的健康。美国有 62 个独立的州、地区和司法管辖区免疫信息系统 (IIS) 网络在运作。这些系统用于实施日益复杂的疫苗接种计划、整合和创建全面的免疫记录,以及监测疫苗的安全性、有效性和支持疫苗接种。尽管这些系统非常重要和必要,但由于系统数量众多,再加上司法管辖区政策和资源的限制,在标准化、互操作性、数据交换以及获取完整的免疫记录方面存在挑战。为了与国家功能标准保持一致,美国免疫登记协会 (AIRA) 与疾病控制中心 (CDC) 和 IIS 合作伙伴合作,于 2015 年启动了其测量和改进 (M&I) 计划,这是一项评估和提高 IIS 与国家功能标准保持一致的创新努力。在全球系统制定更好的方法来实现 2030 年可持续发展目标 (SDG) 目标时,可以借鉴经验和策略,特别是与全球人口健康和基础设施相关的目标。
AIRA 与其合作伙伴密切合作,提出、审查和完善可以在 IIS 之间进行比较的流程和措施,从而为测量提供统一、标准化的方法。M&I 计划作为第三方、独立的评估通过 AIRA 与预生产系统进行连接,以测试 IIS 对测试消息和多个由 IIS 社区优先考虑的内容领域的措施的响应。该过程包括三个阶段:1)测试和发现,2)评估,3)验证。目前评估的内容领域包括临床决策支持、互操作性传输、HL7 提交/确认、HL7 消息查询/响应和数据质量。测试使用由 AIRA 开发的聚合分析报告工具 (AART) 进行,这是一个专门用于编译和可视化来自措施和测试的结果的电子测试工具和用户界面。
M&I 计划是自愿的,截至 2020 年春季,有 86%(50/58)的目标 IIS 计划参与了测量。迄今为止,AIRA 已经积极测量了标准一致性,并在运输、提交/确认和查询/响应这三个内容领域的验证方面发布了数据。在这三个内容领域中的至少两个方面,已有 31 个单独的 IIS 得到了验证。在三年内,符合主要运输措施之一的 IIS 数量从 19 个增加到 39 个,增长了 105%。能够处理患者完整免疫记录正确格式提交的 IIS 数量从 17 个增加到 34 个,增加了 200%。同样,自 2017 年开始测量以来,发送符合标准的 HL7 确认消息的 IIS 数量增加了 14 倍。能够处理和响应请求患者评估免疫记录和预测的查询的 IIS 数量从 9 个增加到 42 个,增加了 367%。在评估的前两个季度中,旨在支持 IIS 与 ACIP 建议保持一致的 CDS 措施的 IIS 符合率从基线增加了 15%。
M&I 计划有助于减少 IIS 之间的差异,并加强 IIS 中的免疫数据,使数据更加完整、准确,并可以更有信心地使用。该计划的成功经验提供了一种创新模式,可以在全球范围内对成功措施和数据共享能力进行标准化,特别是在实现旨在确保所有年龄段健康生活和促进福祉的免疫系统强化的可持续发展目标方面具有重要意义。